EU funding opportunities

Slides:



Advertisements
Similar presentations
European Framework Programme for Business FP7 UK Technology Strategy Board Driving Innovation FP7UK Opportunities in FP 7 The Health research theme Biomed.
Advertisements

EU support for Health Research: from FP6 to FP7
AVV February 2005 Support of the European Union to Research on Rare Diseases Dr Alain Vanvossel European Commission Research Directorate General Health.
1. 2 Key Applications of Genetic and Genomic Testing (slide 1 of 2) Diagnosis of Disease: Whereby genetic or genomic tests are used to screen a patient.
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
©2007 RALPH SNYDERMAN Third Annual Prospective Health Care Conference "Where are We Now?" Ralph Snyderman, MD Chancellor Emeritus, Duke University November.
Who am I? A Brief Bio PhD with John Schrader at The Biomedical Research Centre (UBC) Undergrad at Simon Fraser University Genetics: 3 summers in a Drosophila.
The copyright © is owned by the author of this document. Please do not duplicate. Disclaimer: the „Fit for Health project partners.
Centro di Riferimento Oncologico - CRO Aviano, ITALY FP6 - LIFE SCIENCE, GENOMICS AND BIOTECHNOLOGY FOR HEALTH  VITAL Development of optimized recombinant.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
Pharmacogenomics. Developing drugs on the basis of individual genetic differences Tailoring therapies to genetically similar subpopulations results in.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
The Innovative Medicines Initiative (IMI) High level the IMI Concept, Strategic Research Agenda and Call topics Eva Lindgren.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
R&D IN HUNGARY National Research and Technological Innovation Fund Independent central government office responsible for R&D Expected new budget: approx.
The Innovative Medicines Initiative A winning case for Joint Technology Initiative Status.
Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.
Seventh Framework Programme Theme 1 - Health Ph D.Olguta Iordache Health - NCP.
EURORDIS Eurordis Position on Research Priorities for Rare Diseases.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Consumer Advocate Perspective Clinical Trials Registration Sharon F. Terry, JAM Sharon F. Terry, JAM President and CEO, Genetic Alliance, Inc. Founding.
IncoNet EaP is a project funded under the 7th European Framework Programme for research - Project number EU-Eastern Partnership STI Cooperation.
EU Funding (Cancer) Information Event David Ritchie North West Health Brussels Office.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
SSH in Horizon 2020 Workshop I: Inclusive societies Introduction Peter Farago Conference on „The Place of the Swiss SSH in the EU Horizon 2020“ Berne,
NMBP : Cross-cutting KETs for diagnostics at the point-of-care co-funded by LEIT-NMBP (DG RTD) and LEIT-ICT (DG CONNECT) Opening 20 Sep 2016 Closing.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Digital Genome Market share accounted for over 80% of the North American revenue in 2015.
Diagnostics Scientific Committee
Research on Antimicrobial Resistance
Dr. George Geromichalos, Ph.D.
Open to the World Philippe Cupers European Commission
MRC’s Translational Research Funding
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Industry Perspective: Expanded Access Programs
GO-FAANG Workshop 7-8 October 2015
E-Rare and IRDiRC: Future collaboration perspectives?
Danish (early) FP9 position paper
BBSRC – Agriculture and Food Security Framework
International cooperation in Health
German-Uzbek STI Cooperation
EC initiative on Next Generation sequencing
Call topic identification for 2019 call
Antimicrobial Resistance: Plans for Korea and Beyond
Functional Annotation of the Horse Genome
Priority 3 NMP: generalities
Extracellular vesicles for molecular delivery system
Immune System Project : CD28
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
European Reference Networks Annika Nowak European Commission.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
The Impact of Network Medicine in Gastroenterology and Hepatology
Focus of research group (I)
Overview on proposals submitted to first call SC1 - stage 1
The International Consortium for Personalised Medicine
InfoDay 2013 ENV Calls in FP7 11 June 2012
Clinical Genomics in Inflammatory Bowel Disease
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
The quest for tolerant varieties: phenotyping at plant and cellular level. Chair: Sebastien Carpentier Vice chair: Uli Schurr FA1306 contact:
ICT 29 : Development of novel materials and systems for OLED lighting
A systems view of genetics in chronic kidney disease
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Genomics BioSci. & Tech., SME Located in Taipei city.
12th – 13th November GRANADA
EIP Water European Innovation Partnership on Water
M-H Pinard-van der Laan
Biotechnology & Bioinformatics
Presentation transcript:

EU funding opportunities E-Rare FP-7

E-Rare Only for participating countries (not yet known) The call will be out 11/2010, application by 2/2011 16 projects will be funded, 1 Mio. Euro per year

FP7: ORIENTATION PAPER Proposed priorities for health research 2011 Key research challenges: Epigenomics Supporting innovative clinical trials to verify safety and efficacy

FP7

FP7

ORIENTATION PAPER Proposed priorities for health research 2011 1.1 HIGH-THROUGHPUT RESEARCH …including fundamental genomics that will significantly enhance data generation and improve data and specimen (bio-banks) standardisation, acquisition and analysis. The focus is on new technologies for: sequencing; gene expression, genotyping and phenotyping; structural and functional genomics; bioinformatics and systems biology; other 'omics'. Impact on medicine and SME (6 Mio Euro)

FP7

ORIENTATION PAPER Proposed priorities for health research 2011 1.4-5: New therapeutic approaches in chronic inflammatory and autoimmune diseases. Projects should aim to develop innovative strategies to therapy based on various approaches, such as small molecules, antibodies, peptides or cells, where understanding of mechanism of action has already been established. Cooperation with Brasil, 3 Mio. Euro

FP7 10/2011